ChitnisA.S., HolzbauerS.M., BelflowerR.M., WinstonL.G., BambergW.M., LyonsC.Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.JAMA2013; 173(14): 1359–67.
2.
KeddisM.T., KhannaS., NoheriaA., BaddourL.M., PardiD.S., QianQ.Clostridium difficile infection in patients with chronic kidney disease.Mayo Clin Proc2012; 87: 1046–53.
3.
StridH., FjellA., SimrénM., BjörnssonE.S.Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure.Eur J Gastroenterol Hepatol2009; 21(2): 137–42.
4.
PirainoB., BernardiniJ., BrownE., FigueiredoA., JohnsonD., LyeW.ISPD position statement on reducing the risks of peritoneal dialysis-related infections.Perit Dial Int2011; 31(6): 614–30.
5.
CianciarusoB., KoppleJ.D., TraversoG., PanarelloG., EniaG., StrippoliP.Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients.Am J Kidney Dis1995; 26(3): 475–86.
6.
HenrichT., KrakowerD., BittonA., YokoeD.Clinical risk factors for severe Clostridium difficile-associated disease.Emerg Infect Dis2009; 15(3): 415–22.
7.
HauserA.B., StinghenA.E.M., KatoS., BucharlesS., AitaC., YuzawaY.Characteristics and causes of immune dysfunction related to uremia and dialysis.Perit Dial Int2008; 28(Suppl 3): S183–7.
8.
AndoM., ShibuyaA., YasudaM., AzumaN., TsuchiyaK., AkibaT.Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis.Nephrol Dial Transplant2005; 20(11): 2497–503.
9.
AndoM., ShibuyaA., TsuchiyaK., AkibaT., NittaK.Reduced expression of toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients.Kidney Int2006; 70(2): 358–62.
10.
RyanA., SmithS., AmuS., NelH., McCoyC.A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins.PLOS Pathog2011; 7(6): 1002076.
11.
WuJ., YangX., ZhangY.F., WangY.N., LiuM., DongX.Q.Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.Clin Vaccine Immunol2010; 17(5): 757–63.
NessimS., TomlinsonG., BargmanJ., JassalS.Gastric acid suppression and the risk of enteric peritonitis in peritoneal dialysis patients.Perit Dial Int2008; 28(3): 246–51.
14.
BavishiC., DupontH.L.Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.Aliment Pharmacol Ther2011; 34(11-12): 1269–81.
15.
KwokC.S., ArthurA.K., AnibuezeC.I., SinghS., CavallazziR., LokeY.K.Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.Am J Gastroenterol2012; 107(7): 1011–9.
16.
DanzigerJ., WilliamJ., ScottD., LeeJ., LehmanL., MarkR.Proton-pump inhibitor use is associated with low serum magnesium concentrations.Kidney Int2013; 83(4): 692–9.
